: The global annual incidence of venous thromboembolism (VTE) is estimated to be 0.75-2.69 per 1,000 population (1). Up to 60% of VTE events occur during or within three months after hospital admission: these are known as hospital-associated VTE and account for an estimated 10 million cases of VTE globally (2). Without preventive measures being used, hospital-associated VTE is the leading preventable cause of hospital death (2). The age-standardized pulmonary embolism (PE)-related mortality rate is similar in magnitude to respiratory infections and obstructive pulmonary disease. Although the impact of PE-related deaths is relatively high among young women (3), its global awareness by the public is low (4)
Deep vein thrombosis and pulmonary embolism are significant reasons of chronic illness & death in pe...
Deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboem...
AIM: Information about the variation in the risk for venous thromboembolism (VTE) and in prophylaxis...
: The global annual incidence of venous thromboembolism (VTE) is estimated to be 0.75-2.69 per 1,000...
BACKGROUND: Information about the variation in the risk for venous thromboembolism (VTE) and in prop...
387-394Information about the variation in the risk for venous thromboembolism (VTE) and in prophylax...
International audienceThe incidence of venous thromboembolism has been studied during one year in a ...
International audienceVenous thromboembolism (VTE) is often asymptomatic, mis-diagnosed, and unrecog...
Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis u...
Limited data are available regarding the risk for venous thromboembolism (VTE) and VTE prophylaxis u...
Introduction: Venous thromboembolism (VTE) is a leading cause of cardiovascular morbidity and mortal...
Abstract Background Venous thromboembolism (VTE) is a silent and potentially lethal disease that a...
Deep vein thrombosis and pulmonary embolism are associated with considerable morbidity and mortality...
Presented to the 11th Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held at ...
Q1Q1736-748Limited data are available regarding the risk for venous thromboembolism (VTE) and VTE p...
Deep vein thrombosis and pulmonary embolism are significant reasons of chronic illness & death in pe...
Deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboem...
AIM: Information about the variation in the risk for venous thromboembolism (VTE) and in prophylaxis...
: The global annual incidence of venous thromboembolism (VTE) is estimated to be 0.75-2.69 per 1,000...
BACKGROUND: Information about the variation in the risk for venous thromboembolism (VTE) and in prop...
387-394Information about the variation in the risk for venous thromboembolism (VTE) and in prophylax...
International audienceThe incidence of venous thromboembolism has been studied during one year in a ...
International audienceVenous thromboembolism (VTE) is often asymptomatic, mis-diagnosed, and unrecog...
Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis u...
Limited data are available regarding the risk for venous thromboembolism (VTE) and VTE prophylaxis u...
Introduction: Venous thromboembolism (VTE) is a leading cause of cardiovascular morbidity and mortal...
Abstract Background Venous thromboembolism (VTE) is a silent and potentially lethal disease that a...
Deep vein thrombosis and pulmonary embolism are associated with considerable morbidity and mortality...
Presented to the 11th Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held at ...
Q1Q1736-748Limited data are available regarding the risk for venous thromboembolism (VTE) and VTE p...
Deep vein thrombosis and pulmonary embolism are significant reasons of chronic illness & death in pe...
Deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboem...
AIM: Information about the variation in the risk for venous thromboembolism (VTE) and in prophylaxis...